drugset / Trial / NCT05928585
A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this clinical trial is to test safety of the investigational product in healthy volunteers. The main questions it aims to answer is when HIB210 is administered as multiple doses, is it: 1. Safe 2. Well tolerated 3. Does the body absorb and eliminate HIB210 as expected
Timeline
- Start
- 2023-07-06
- Primary completion
- 2024-06-10
- Completion
- 2024-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HIB210 | Monoclonal antibody | — | — |